IL42313A - Pharmaceutical composition containing glycyrrhetinic acid for the treatment of oesophagitis - Google Patents

Pharmaceutical composition containing glycyrrhetinic acid for the treatment of oesophagitis

Info

Publication number: IL42313A
Authority: IL; Israel
Prior art keywords: pharmaceutical composition; weight; composition according; glycyrrhetinic acid; amount
Prior art date: 1972-12-18

Application number

IL42313A

Other languages

English (en)

Other versions

IL42313A0 (en

Original Assignee

Biorex Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-12-18

Filing date

1973-05-20

Publication date

1976-08-31

1973-05-20 Application filed by Biorex Laboratories Ltd filed Critical Biorex Laboratories Ltd

1973-07-30 Publication of IL42313A0 publication Critical patent/IL42313A0/xx

1976-08-31 Publication of IL42313A publication Critical patent/IL42313A/en

Links

239000008194 pharmaceutical composition Substances 0.000 title claims abstract 12
MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 title claims abstract 9
MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 title claims abstract 4
229960003720 enoxolone Drugs 0.000 title claims abstract 4
206010030216 Oesophagitis Diseases 0.000 title claims 2
231100000252 nontoxic Toxicity 0.000 claims abstract 6
230000003000 nontoxic effect Effects 0.000 claims abstract 6
150000003839 salts Chemical class 0.000 claims abstract 5
-1 antacid compound Chemical class 0.000 claims abstract 4
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims abstract 3
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims abstract 3
239000000783 alginic acid Substances 0.000 claims abstract 3
229960001126 alginic acid Drugs 0.000 claims abstract 3
235000010443 alginic acid Nutrition 0.000 claims abstract 3
229920000615 alginic acid Polymers 0.000 claims abstract 3
150000004781 alginic acids Chemical class 0.000 claims abstract 3
229940069428 antacid Drugs 0.000 claims abstract 3
239000003159 antacid agent Substances 0.000 claims abstract 3
230000001458 anti-acid effect Effects 0.000 claims abstract 3
239000001913 cellulose Substances 0.000 claims abstract 3
229920002678 cellulose Polymers 0.000 claims abstract 3
230000003110 anti-inflammatory effect Effects 0.000 claims abstract 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 1
238000004040 coloring Methods 0.000 claims 1
239000003937 drug carrier Substances 0.000 claims 1
239000000796 flavoring agent Substances 0.000 claims 1
235000013355 food flavoring agent Nutrition 0.000 claims 1
235000003599 food sweetener Nutrition 0.000 claims 1
239000000463 material Substances 0.000 claims 1
239000008024 pharmaceutical diluent Substances 0.000 claims 1
239000003765 sweetening agent Substances 0.000 claims 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL42313A 1972-12-18 1973-05-20 Pharmaceutical composition containing glycyrrhetinic acid for the treatment of oesophagitis IL42313A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB5835472A GB1390683A (en)	1972-12-18	1972-12-18	Pharmaceutical composition

Publications (2)

Publication Number	Publication Date
IL42313A0 IL42313A0 (en)	1973-07-30
IL42313A true IL42313A (en)	1976-08-31

Family

ID=10481401

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL42313A IL42313A (en)	1972-12-18	1973-05-20	Pharmaceutical composition containing glycyrrhetinic acid for the treatment of oesophagitis

Country Status (14)

Country	Link
US (1)	US3944660A (fr)
BE (1)	BE802700A (fr)
CA (1)	CA1006091A (fr)
DE (1)	DE2360918C3 (fr)
ES (1)	ES414093A1 (fr)
FR (1)	FR2210399B1 (fr)
GB (1)	GB1390683A (fr)
HK (1)	HK41078A (fr)
IE (1)	IE38520B1 (fr)
IL (1)	IL42313A (fr)
KE (1)	KE2853A (fr)
MY (1)	MY7800368A (fr)
NL (1)	NL164472C (fr)
ZA (1)	ZA732438B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU179474B (en) *	1978-02-24	1982-10-28	Laszlo Gyarmati	Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
US4184888A (en) *	1978-03-01	1980-01-22	Dap Inc.	Effervescent adhesive-forming product
US4254111A (en) *	1978-07-05	1981-03-03	Roecar Holdings (Netherlands Antilles) Nv	Sterolin products
ZA82361B (en) *	1981-02-06	1982-12-29	Biorex Laboratories Ltd	Pharmaceutical composition for treating diseases of the oral cavity
ES511731A0 (es) *	1981-06-01	1983-07-01	Orion Yhtymae Oy	"un metodo para preparar tabletas a base de polvos de medicamento acidicos, inocuas para el esofago".
FR2525474A1 (fr) *	1982-04-26	1983-10-28	Roussel Uclaf	Nouvelle forme pharmaceutique orale de clometacine
DE3366910D1 (en) *	1982-04-27	1986-11-20	Noristan Ltd	Pharmaceutical compositions and preparation thereof
AU553789B2 (en) *	1982-06-30	1986-07-24	Biorex Laboratories Ltd.	Glycyrrhetinic acid derivatives in cream compositions
GB2122893B (en) *	1982-06-30	1985-06-26	Biorex Laboratories Ltd	Glycyrrhetinic acid compositions
WO1987004077A1 (fr) *	1986-01-03	1987-07-16	The University Of Melbourne	Composition contre les reflux gastro-oesophagiens
US5112804A (en) *	1987-04-01	1992-05-12	Temple University Of The Commonwealth System Of Higher Education	Pharmaceutical composition and method of intranasal administration
NL8902338A (nl) *	1988-09-20	1990-04-17	Glaxo Group Ltd	Farmaceutische preparaten.
US4891221A (en) *	1988-11-23	1990-01-02	Edward Shanborm	Whole blood antiviral process and composition
EP0484106A1 (fr) *	1990-11-01	1992-05-06	Merck & Co. Inc.	Compositions à libération contrôlée
DE102006037298A1 (de) *	2006-08-08	2008-02-14	Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh	Pharmazeutische Zusammensetzung, insbesondere Antazidum
ITMI20121916A1 (it) *	2012-11-09	2014-05-10	Velleja Res Srl	Formulati a cessione intra-gastrica ritardata a base di derivati della glycyrrhiza glabra

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES296176A1 (es)	1964-02-06	1964-05-16	Ferrer Labor	Un nuevo compuesto del acido glicirretinico de actividad medicamentosa y su procedimiento de fabricaciën
GB1093286A (en) *	1965-02-15	1967-11-29	Biorex Laboratories Ltd	Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3764618A (en) *	1970-10-27	1973-10-09	Dott Inverni & Della Beffa S P	Aluminum salts of 3-acetyl-18{62 -glycyrrhetinic acid

1972
- 1972-12-18 GB GB5835472A patent/GB1390683A/en not_active Expired
1973
- 1973-04-09 ZA ZA732438A patent/ZA732438B/xx unknown
- 1973-04-26 ES ES414093A patent/ES414093A1/es not_active Expired
- 1973-05-20 IL IL42313A patent/IL42313A/en unknown
- 1973-07-23 BE BE133789A patent/BE802700A/fr not_active IP Right Cessation
- 1973-07-30 FR FR7327832A patent/FR2210399B1/fr not_active Expired
- 1973-11-16 IE IE2081/73A patent/IE38520B1/xx unknown
- 1973-11-28 US US05/419,487 patent/US3944660A/en not_active Expired - Lifetime
- 1973-12-06 DE DE2360918A patent/DE2360918C3/de not_active Expired
- 1973-12-17 CA CA188,349A patent/CA1006091A/en not_active Expired
- 1973-12-17 NL NL7317238.A patent/NL164472C/xx not_active IP Right Cessation
1978
- 1978-07-06 KE KE2853A patent/KE2853A/xx unknown
- 1978-07-20 HK HK410/78A patent/HK41078A/xx unknown
- 1978-12-31 MY MY1978368A patent/MY7800368A/xx unknown

Also Published As

Publication number	Publication date
KE2853A (en)	1978-08-04
GB1390683A (en)	1975-04-16
DE2360918C3 (de)	1978-07-20
AU6312673A (en)	1975-06-05
IL42313A0 (en)	1973-07-30
FR2210399B1 (fr)	1977-01-28
NL164472C (nl)	1981-01-15
NL164472B (nl)	1980-08-15
MY7800368A (en)	1978-12-31
ES414093A1 (es)	1981-08-16
DE2360918A1 (de)	1974-06-27
DE2360918B2 (de)	1977-11-10
BE802700A (fr)	1974-01-23
US3944660A (en)	1976-03-16
IE38520B1 (en)	1978-03-29
FR2210399A1 (fr)	1974-07-12
IE38520L (en)	1974-06-18
CA1006091A (en)	1977-03-01
HK41078A (en)	1978-07-28
NL7317238A (fr)	1974-06-20
ZA732438B (en)	1974-01-30

Publication	Publication Date	Title
IL42313A (en)	1976-08-31	Pharmaceutical composition containing glycyrrhetinic acid for the treatment of oesophagitis
CA2054189A1 (fr)	1990-10-18	Compositions stables d'acide ascorbique
KR910004185A (ko)	1991-03-28	세포독소 약제에 대항하는 암세포의 다약제 내성의 역전을 위한 화합물 및 그 사용
DE3065420D1 (en)	1983-12-01	Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours
GB1298494A (en)	1972-12-06	Phenylethanolamine derivatives
JPS5492951A (en)	1979-07-23	Novel aminoglycoside derivative
JPS53136513A (en)	1978-11-29	Stabilization of prostaglandin-x-related compounds
IE36510L (en)	1973-01-06	Anti-seborrhoeic compositions
JPS527428A (en)	1977-01-20	Method for preserving foods
JPS52108028A (en)	1977-09-10	Remedies for dysacousis
IE40296L (en)	1975-06-10	Quinoline-and pyridine-carbamates
CA2016470A1 (fr)	1990-11-11	Preparation pharmaceutique et methode de traitement du dysfonctionnement hepatique
JPS52136159A (en)	1977-11-14	Anti/malignanttumor containing the same as active ingredients
GB1362845A (en)	1974-08-07	Benzyl alcohol derivatives
DE2963545D1 (en)	1982-10-07	Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
ES404959A1 (es)	1975-07-01	Un procedimiento para preparar una composicion acuosa es- table de dexiciclina.
KR890012960A (ko)	1989-09-20	결정성 β-락탐 용매화물
JPS5259186A (en)	1977-05-16	Preparation of 3-cephem compounds by reduction
IE34590B1 (en)	1975-06-25	Phenylethanolamine derivatives
GB1449404A (en)	1976-09-15	N-arylsulphonyl urea derivatives
ES472528A1 (es)	1979-10-01	Procedimiento para la preparacion de derivados de benzosul- fonamida
IL42314A (en)	1976-09-30	Pharmaceutical composition containing a glycyrrehetinic acid derivative and an antacid for the treatment of gastritis
SU504532A1 (ru)	1976-02-28	Бактерицидна и фунгицидна композици
JPS5233662A (en)	1977-03-14	Preparation of n2-naphthalenesulfonyl-alginamides and acid addition sa lts thereof
JPS5432487A (en)	1979-03-09	Preparation of 1-carbamoyluracils